Vimarsana
Biggest News Aggregation in the World

Page 6 - Science Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Science Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Science Ventures Today - Breaking & Trending Today

Phase Four aims to roll out its next-gen plasma thruster in the first half of 2022 – TechCrunch - Vimarsana News

Phase Four aims to roll out its next-gen plasma thruster in the first half of 2022 – TechCrunch

Space startup Phase Four will be rolling out the next generation of its Maxwell radio-frequency plasma propulsion system next year, which the company says offers key performance improvements to allow spacecraft using it a wider range of maneuverability in orbit. In general, when moving a satellite around in the vacuum of space, one cares about […]

Novadip Biosciences announces EUR 19 million Series B - Vimarsana News

Novadip Biosciences announces EUR 19 million Series B

Novadip Biosciences announces EUR 19 million Series B financing backed by international investors New investment to fuel continued growth of 3M³ platform...

Novadip Biosciences announces EUR 19 million Series B financing backed by international investors - Vimarsana News

Novadip Biosciences announces EUR 19 million Series B financing backed by international investors

Novadip Biosciences announces EUR 19 million Series B financing backed by international investors - read this article along with other careers information, tips and advice on BioSpace

Xilio, Ventyx IPOs raise $269M to fuel plans to compete with big pharma drugs - Vimarsana News

Xilio, Ventyx IPOs raise $269M to fuel plans to compete with big pharma drugs

Cancer drug developer Xilio Therapeutics and Ventyx Biosciences, a company with drug candidates in cancer and autoimmune diseases, are the latest life science companies to go public. They’ll use proceeds from their respective IPOs to continue clinical development of drugs being positioned as competitors to drugs from big pharmaceutical companies.

BrightVolt Raises $16 Million in Series B Funding Led by - Vimarsana News

BrightVolt Raises $16 Million in Series B Funding Led by

REDMOND, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- BrightVolt, Inc., a global leader in the design, development, and manufacturing of safe, high energy...